ADCYAP1 and kidney failure: In addition to these factors, decreased PACAP level also influences the development and progression of disease-related organ damage such as renal failure and bone lesions, as a result of the peptide’s antiproliferative action as well as the protective effect in proximal tubule cells and the inhibitory effect on osteoclasts [23,24,25].